Conference Coverage: 2024 Chronic Disease at Work

For nearly 10 years, Benefits Canada’s Chronic Disease at Work conference has examined the current trends in chronic disease in Canada and what they mean for plan sponsors.

On Feb. 8, insurers and health-care professionals shared their insights into several chronic conditions impacting Canadian employees, including Alzheimer’s disease, inflammatory bowel disease, menopause and pulmonary arterial hypertension.

Here's what you missed!

2024 CDAW speakers

Carmen Bellows
Sun Life Financial

Patricia Lee
Canadian Women with Fibroids

Dr. Mita Manna
University of Saskatchewan

How employers can prioritize women’s health in benefits plans

Amid a wave of frank and open discussions about women’s health, more plan sponsors are beginning to review their benefits and human resources policies with an eye to providing better support.

This session has been made possible by AstraZeneca Canada, Pfizer Canada and Sun Life.

Read session coverage

Janet Ko
the Menopause Foundation of Canada
A closer look at menopause-inclusive workplaces

Employers can support employees going through menopause by improving their workplace culture, communication and accommodation policies and employee benefits.

This session was made possible by Astellas.

Read session coverage

Laura Tamblyn Watts
CanAge
Plan members with Alzheimer’s still have plenty to offer the workplace: patient advocate

After her husband Mike Kessler was diagnosed with mild Alzheimer’s disease in 2021, Karen Kessler admitted she would hover around him.

This session was made possible by Eisai.

Read session coverage

Dr. John Granton
University Health Network
What employers need to know about pulmonary arterial hypertension

Employees with pulmonary arterial hypertension can experience significant impacts to their quality of life and workplace experience.

This session was made possible by Merck.

Read session coverage

Dr. Vipul Jairath
Western University
How plan sponsors can support employees with inflammatory bowel disease

With the increased availability of treatments for inflammatory bowel disease, patients can achieve longer periods of remission.

This session has been made possible by Takeda.

Read session coverage

Sponsors

To view highlights from the 2023 Chronic Disease at Work conference, click here.

To view highlights from the 2022 Chronic Disease at Work conference, click here.

To view highlights from the 2021 Chronic Disease at Work conference, click here.